Spring Bank Pharmaceuticals

Patient dies in a troubled HBV drug program — forcing developers to scrap the drug and shift focus
Endpoints
Wed, 01/29/20 - 10:31 am
hepatitis B
Spring Bank Pharmaceuticals
clinical trials
patient deaths
inarigivir soproxil
Spring Bank Pharma shares slide 45% premarket after it halts trial of treatment for hepatitis B virus
Marketwatch
Mon, 12/30/19 - 10:37 am
Spring Bank Pharmaceuticals
hepatitis B
clinical trials
FDA
inarigivir soproxil